Clinical Trials on Plaque Psoriasis in Canada
Total 400 results
-
Escalier Biosciences B.V.Innovaderm Research Inc.CompletedPsoriatic PlaqueUnited States, Canada
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Forward-Pharma GmbHWithdrawnPlaque PsoriasisCanada
-
Kineta Inc.Completed
-
Innovaderm Research Inc.Recruiting
-
Dermatrials ResearchAmgenCompletedPlaque PsoriasisCanada
-
Merck KGaA, Darmstadt, GermanyTerminatedPlaque PsoriasisCanada
-
UCB Biopharma SRLRecruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
Akros Pharma Inc.CompletedSkin Diseases | Psoriasis | Plaque PsoriasisCanada
-
MedImmune LLCCompletedChronic Plaque PsoriasisCanada
-
Merck KGaA, Darmstadt, GermanyTerminated
-
PRCL Research Inc.CompletedPlaque Psoriasis | Psoriasis VulgarisCanada, Slovakia, Ukraine
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Innovaderm Research Inc.AbbottCompleted
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
Galderma R&DCompletedPlaque PsoriasisUnited States, Canada
-
ApoPharmaCompletedPlaque PsoriasisUnited States, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
TakedaCompleted
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Canada, Germany, France, Spain, Poland
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Arcutis Biotherapeutics, Inc.CompletedMaximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)Psoriasis | Plaque PsoriasisUnited States, Canada, Dominican Republic
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Akros Pharma Inc.TerminatedSkin Diseases | Plaque PsoriasisUnited States, Canada
-
Astellas Pharma IncCompleted
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
-
Akros Pharma Inc.CompletedSkin Diseases | Psoriasis | Plaque PsoriasisUnited States, Canada, Poland
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
Incyte CorporationCompletedPlaque PsoriasisUnited States, Canada
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, Germany, United States, Iceland, Canada, Poland
-
Galderma R&DCompletedChronic Plaque PsoriasisUnited States, Canada
-
Astellas Pharma IncCompletedChronic Plaque PsoriasisUnited States, Canada
-
Meiji Pharma USA Inc.CompletedPlaque PsoriasisUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedMaximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)Psoriasis | Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Dermavant Sciences, Inc.RecruitingPlaque PsoriasisUnited States, Canada
-
Can-Fite BioPharmaCompletedPlaque PsoriasisIsrael, Serbia, Romania, Croatia, Bosnia and Herzegovina, Bulgaria, Canada, Moldova, Republic of, Poland
-
Galderma R&DCompletedPlaque PsoriasisUnited States, Spain, Germany, Italy, Belgium, Canada, Hungary
-
Eli Lilly and CompanyCompletedA Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)Plaque PsoriasisGermany, Spain, Belgium, France, Hungary, Austria, Canada, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Terminated
-
Eli Lilly and CompanyCompletedPlaque PsoriasisPuerto Rico, United States, Germany, Poland, Japan, Canada
-
AmgenCompletedPlaque PsoriasisSpain, United States, Canada, Germany, Denmark, France, Italy, Switzerland, Austria
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisUnited States, Korea, Republic of, Hungary, United Kingdom, Canada, Germany, Poland, Turkey, Taiwan, Spain, Argentina
-
Arcutis Biotherapeutics, Inc.CompletedPlaque PsoriasisUnited States, Australia, Bulgaria, Canada
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Austria, Canada, Poland
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisUnited States, Korea, Republic of, Germany, France, Taiwan, Japan, Spain, United Kingdom, Poland, Canada